Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT7 | O95251 | 7/20 | 0.41 |
| ▸ | KAT6A | Q92794 | 7/20 | 0.41 |
| ▸ | KAT6B | Q8WYB5 | 6/20 | 0.41 |
| ▸ | KAT5 | Q92993 | 4/20 | 0.41 |
| ▸ | KAT8 | Q9H7Z6 | 4/20 | 0.41 |
| ▸ | BRD4 | O60885 | 2/20 | 0.38 |
| ▸ | BRD2 | P25440 | 2/20 | 0.38 |
| ▸ | BRD3 | Q15059 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | ALPL | P05186 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24429771 | 0.87 | KAT7 (0.42) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL29652415 | 0.83 | KAT7 (0.37) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL31605613 | 0.80 | KAT6A (0.60) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL21596870 | 0.80 | KAT6A (0.60) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL21660335 | 0.78 | BRD4 (0.40) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL21596865 | 0.76 | KAT6A (0.57) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL31605637 | 0.76 | KAT6A (0.57) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL21660533 | 0.76 | POLB (0.41) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL21609057 | 0.72 | KAT6A (0.57) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL29652392 | 0.72 | KAT7 (0.38) | KAT7KAT6AKAT6BKAT5KAT8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220153710-A1 | Compounds | CTXT PTY LTD (AU) | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220153710-A1 | Compounds | SLC10A1, ABCB11, PCSK9 | KAT7 490/4885KAT6A 877/4885KAT6B 1005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.